Shinn Discusses Dying City with Guare March 28 | Playbill

Related Articles
News Shinn Discusses Dying City with Guare March 28 Christopher Shinn will discuss his new play Dying City with the playwright John Guare at a Lincoln Center Theater Platform Series discussion in the lobby of the Vivian Beaumont Theater March 28 at 6 PM.

The event occurs just before the evening performance of the play, which is currently making its American premiere Off-Broadway at LCT's Mitzi E. Newhouse Theater, where it began previews Feb. 15 and opened March 4.

Pablo Schreiber and Rebecca Brooksher star, and James MacDonald directs. MacDonald also directed the play's world premiere at London's Royal Court Theatre in spring 2006.

Brooksher plays Kelly, a young therapist whose husband dies in the war in Iraq. One year later, the husband's identical twin brother (Schreiber) arrives at Kelly's door, looking for answers to questions about his brother's death.

Shinn's plays include Where Do We Live at the Vineyard Theatre (Obie Award for Playwriting), Four at Manhattan Theatre Club, What Didn't Happen and On the Mountain at Playwrights Horizons, The Coming World and Other People.

Guare is the writer of the plays The House of Blue Leaves, Six Degrees of Separation, Four Baboons Adoring the Sun, A Few Stout Individuals, Lydie Breeze, Marco Polo Sings a Solo, Landscape of the Body and Chaucer in Rome and the libretto of the musical Two Gentlemen of Verona, among other works. For the discussion, admission is free and available on a first-come, first-served basis, beginning at 5:30 PM. Speakers and schedules are subject to change. Call (212) 362-7600 to confirm on the day of the event.

The discussion will take place in the lobby of the Vivian Beaumont Theater at 150 West 65th Street. For more information visit For tickets to Dying City, visit the box office or contact Telecharge at (212) 239-6200 or

Today’s Most Popular News:

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting with your ad blocker.
Thank you!